Ocugen intends to sell 100 million doses of COVAXIN in US in 2021
Cracking the US market would be a significant milestone for the company and India’s vaccine industry
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Pharma MSMEs seek government intervention to tackle shortage, price increase of raw materials
Caution that if the situation continues, there could be a scarcity of medicines in the country
Alkem launches anti-epileptic drug BRIVASURE (Brivaracetam)
Brivaracetam has shown promise in patients with epilepsy whose seizures persist despite adequate treatment.
Doctors keen to adopt novel biomarkers for immuno-oncology regimens: GlobalData
The most promising or anticipated biomarker among high-prescribing physicians in the seven major markets was identified to be…
NATCO ventures into Pheromone based tech for Integrated Pest Management
NATCO ventures into pheromone-based tech for integrated pest management
Gilead, Merck sign pact to develop, commercialise long-acting HIV treatment combinations
Collaboration to focus on oral and injectable formulations of Lenacapavir and Islatravir
Strides gets USFDA approval for Potassium Chloride for Oral Solution
Potassium Chloride Oral Solution is indicated for the treatment and prophylaxis of hypokalemia
COVID-19 has created a level playing field for innovators to get their products to market
Ashutosh Mayank and Prajakt Raut, Managing Partners at Supply Chain Labs, Lumis Partners share their insights on new opportunities…
Sun Pharma, Dr Reddy’s, Aurobindo, Jubilant recall products in US
The Indian firms have initiated recall of these products for various reasons including failed impurities/degradation…
CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData
Three leading companies racing to bring CRISPR therapies to the clinic are CRISPR Therapeutics, Intellia Therapeutics and Editas…
Abbott forms Pandemic Defense Coalition
It is a global scientific network dedicated to the early detection of, and rapid response to, future pandemic threats
China continues to lead high value oncology deals in APAC: GlobalData
High-value deals have dominated the Asia-Pacific (APAC) pharma strategic partnership landscape in 2020. Within the region, China…
Hikma, GSK stop talks over potential buyout deal of Egypt, Tunisia assets
Hikma had said in January that it was planning to buy those assets
Parikh family sells stake in ZCL Chemicals to Advent in Rs 2,000 crore deal
The transaction marks one of the largest exits in the API space
AstraZeneca Pharma India gets DCGI approval for Osimertinib tablets
It is now approved as monotherapy for adjuvant treatment after complete tumour resection in patients with NSCLC
Lupin launches Nitazoxanide Tablets
They are indicated in the treatment of diarrhoea caused by Giardia lamblia or Cryptosporidium parvum
Indoco launches Brinzolamide Ophthalmic Suspension 1% in US by Teva Pharma
It is used to treat high pressure inside the eye due to ocular hypertension and open-angle glaucoma
Lupin Pharma Canada, Endoceutics to partner for commercialisation of Intrarosa
It is indicated for the treatment of postmenopausal vulvovaginal atrophy offered as a vaginal ovule containing 6.5 mg of…
Vaishali Pharma receives orders from Vanuatu Islands, Samoa Islands
It has been awarded two tenders for the supply of surgical and pharma products
US FDA nod for Roche’s VENTANA ALK (D5F3) CDx assay as companion diagnostic for NSCLC…
The VENTANA ALK (D5F3) CDx Assay is now FDA approved as a companion diagnostic in four targeted treatments